A Survey on National Pediatric Antibiotic Stewardship Programs, Networks and Guidelines in 23 European Countries

Ioannis Kopsidas1, Stefania Vergnano2, Nikos Spyridis3

  • 1From the Penta Foundation, Padua, Italy.

Insights

Pediatric antibiotic stewardship (PAS) programs in Europe show fragmented implementation, with few national guidelines, competencies, or agreed metrics for antibiotic prescribing in children, contributing to antimicrobial resistance.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Pharmacology

Background:

  • Antimicrobial resistance (AMR) is a significant public health concern across Europe, exacerbated by antimicrobial misuse and overuse.
  • Pediatric antibiotic stewardship (PAS) is crucial for combating AMR in children.

Purpose of the Study:

  • To assess the current landscape of pediatric antibiotic stewardship (PAS) programs in Europe.
  • To identify existing gaps in national PAS programs, networks, and guidelines.

Main Methods:

  • A 17-question survey was distributed in July 2019 to European pediatric infectious disease experts.
  • The survey focused on the presence of national PAS programs, networks, guidelines, competencies, and metrics.

Main Results:

  • Responses were received from 23 countries, revealing varied implementation of national guidelines (70%), with many outdated.
  • Few countries have established national PAS competencies (4/23) or networks (UK, Germany).
  • A significant gap exists in agreed metrics for pediatric antibiotic prescribing (91% of countries lack them).

Conclusions:

  • The fragmented implementation of PAS programs, lack of standardized metrics, and absence of national networks and competencies are concerning.
  • These gaps hinder effective antimicrobial stewardship in pediatric populations, potentially worsening antimicrobial resistance across Europe.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
147
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
111
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.5K
Antibiotic Selection00:57

Antibiotic Selection

Overview
58.8K